EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,276,549 | -29.1% | 207,771 | -12.6% | 0.00% | – |
| Q2 2023 | $4,621,121 | -59.6% | 237,712 | -41.0% | 0.00% | -100.0% |
| Q1 2023 | $11,430,784 | -79.5% | 402,918 | -78.8% | 0.00% | -50.0% |
| Q4 2022 | $55,655,440 | +108.2% | 1,904,052 | +88.2% | 0.00% | 0.0% |
| Q3 2022 | $26,730,000 | -22.5% | 1,011,747 | +30.4% | 0.00% | 0.0% |
| Q2 2022 | $34,471,000 | -2.7% | 775,860 | +8.4% | 0.00% | 0.0% |
| Q1 2022 | $35,429,000 | -1.8% | 715,884 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $36,063,000 | -8.8% | 708,224 | -0.1% | 0.00% | 0.0% |
| Q3 2021 | $39,545,000 | +25.2% | 708,945 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $31,577,000 | -5.7% | 737,786 | -8.1% | 0.00% | 0.0% |
| Q1 2021 | $33,500,000 | -11.6% | 802,584 | -1.4% | 0.00% | 0.0% |
| Q4 2020 | $37,913,000 | +12.3% | 814,101 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $33,774,000 | -9.7% | 795,055 | +2.0% | 0.00% | -33.3% |
| Q2 2020 | $37,415,000 | +30.0% | 779,797 | +24.7% | 0.00% | 0.0% |
| Q1 2020 | $28,772,000 | -21.6% | 625,470 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $36,684,000 | +19.8% | 610,591 | +12.8% | 0.00% | +50.0% |
| Q3 2019 | $30,623,000 | -16.2% | 541,327 | -17.5% | 0.00% | -33.3% |
| Q2 2019 | $36,534,000 | +10.9% | 656,136 | +0.6% | 0.00% | 0.0% |
| Q1 2019 | $32,933,000 | -1.1% | 652,265 | -21.1% | 0.00% | 0.0% |
| Q4 2018 | $33,309,000 | -49.5% | 826,735 | -13.1% | 0.00% | -40.0% |
| Q3 2018 | $65,926,000 | +30.6% | 950,861 | +42.5% | 0.01% | +25.0% |
| Q2 2018 | $50,481,000 | +16.8% | 667,242 | -18.6% | 0.00% | 0.0% |
| Q1 2018 | $43,202,000 | +5.3% | 819,915 | +6.8% | 0.00% | +33.3% |
| Q4 2017 | $41,016,000 | -29.5% | 767,781 | -21.3% | 0.00% | -40.0% |
| Q3 2017 | $58,155,000 | +5.8% | 975,015 | +40.0% | 0.01% | 0.0% |
| Q2 2017 | $54,949,000 | +17.7% | 696,466 | +23.7% | 0.01% | +25.0% |
| Q1 2017 | $46,685,000 | -10.0% | 562,865 | -13.9% | 0.00% | -20.0% |
| Q4 2016 | $51,855,000 | +32.5% | 653,521 | +16.9% | 0.01% | +25.0% |
| Q3 2016 | $39,128,000 | +121.2% | 558,958 | +22.6% | 0.00% | +100.0% |
| Q2 2016 | $17,687,000 | -30.6% | 455,938 | -27.6% | 0.00% | -33.3% |
| Q1 2016 | $25,489,000 | -25.0% | 629,493 | +64.3% | 0.00% | -25.0% |
| Q4 2015 | $33,983,000 | +7.0% | 383,231 | -10.7% | 0.00% | 0.0% |
| Q3 2015 | $31,754,000 | -10.3% | 428,986 | -2.0% | 0.00% | 0.0% |
| Q2 2015 | $35,388,000 | +13777.6% | 437,630 | +7074.3% | 0.00% | – |
| Q1 2015 | $255,000 | -5.9% | 6,100 | -71.3% | 0.00% | – |
| Q1 2014 | $271,000 | – | 21,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |